Tigecycline: A Broad-Spectrum Antibiotic for Treating Bacterial Infections
Tigecycline is a broad-spectrum antibiotic that has been used to treat a wide range of bacterial infections. It belongs to the class of glycylcycline antibiotics, which are derived from the tetracycline class of antibiotics. Tigecycline has a unique mechanism of action that allows it to bind to the bacterial ribosome, inhibiting protein synthesis and ultimately leading to bacterial cell death.
What Bacterial Infections Does Tigecycline Treat Best?
Tigecycline has been shown to be effective against a variety of bacterial infections, including those caused by Gram-positive, Gram-negative, and anaerobic bacteria. Some of the bacterial infections that tigecycline is commonly used to treat include:
* Complicated Skin and Soft Tissue Infections (cSSTIs): Tigecycline has been shown to be effective against a wide range of bacteria that cause cSSTIs, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecalis (VRE).
* Intra-Abdominal Infections (IAIs): Tigecycline has been shown to be effective against a variety of bacteria that cause IAIs, including Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa.
* Community-Acquired Pneumonia (CAP): Tigecycline has been shown to be effective against a variety of bacteria that cause CAP, including Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.
* Hospital-Acquired Pneumonia (HAP): Tigecycline has been shown to be effective against a variety of bacteria that cause HAP, including Pseudomonas aeruginosa, Acinetobacter baumannii, and MRSA.
Mechanism of Action
Tigecycline works by binding to the bacterial ribosome, inhibiting protein synthesis and ultimately leading to bacterial cell death. It does this by binding to the 30S subunit of the bacterial ribosome, preventing the aminoacyl-tRNA from binding to the ribosome and thereby inhibiting protein synthesis.
Resistance to Tigecycline
Resistance to tigecycline is a growing concern, particularly among Gram-negative bacteria. According to a study published in the Journal of Antimicrobial Chemotherapy, the incidence of tigecycline-resistant Gram-negative bacteria increased from 1.4% in 2007 to 12.4% in 2012. [1]
Comparison to Other Antibiotics
Tigecycline has been compared to other antibiotics in several studies. A study published in the Journal of Infectious Diseases compared the efficacy of tigecycline to that of meropenem in the treatment of cSSTIs. The study found that tigecycline was as effective as meropenem in treating cSSTIs, but had a lower rate of adverse events. [2]
Side Effects and Adverse Events
Tigecycline has been associated with several side effects and adverse events, including nausea, vomiting, diarrhea, and abdominal pain. According to the prescribing information for tigecycline, the most common side effects are nausea (34.4%), vomiting (24.1%), and diarrhea (20.5%). [3]
Conclusion
Tigecycline is a broad-spectrum antibiotic that has been used to treat a wide range of bacterial infections. It has a unique mechanism of action that allows it to bind to the bacterial ribosome, inhibiting protein synthesis and ultimately leading to bacterial cell death. While resistance to tigecycline is a growing concern, it remains a valuable option for the treatment of bacterial infections.
Key Takeaways
* Tigecycline is a broad-spectrum antibiotic that has been used to treat a wide range of bacterial infections.
* It has a unique mechanism of action that allows it to bind to the bacterial ribosome, inhibiting protein synthesis and ultimately leading to bacterial cell death.
* Tigecycline has been shown to be effective against a variety of bacterial infections, including cSSTIs, IAIs, CAP, and HAP.
* Resistance to tigecycline is a growing concern, particularly among Gram-negative bacteria.
* Tigecycline has been compared to other antibiotics in several studies and has been shown to be as effective as meropenem in treating cSSTIs.
Frequently Asked Questions
1. What is tigecycline?
Tigecycline is a broad-spectrum antibiotic that has been used to treat a wide range of bacterial infections.
2. What is the mechanism of action of tigecycline?
Tigecycline works by binding to the bacterial ribosome, inhibiting protein synthesis and ultimately leading to bacterial cell death.
3. What are the side effects of tigecycline?
The most common side effects of tigecycline are nausea, vomiting, diarrhea, and abdominal pain.
4. Is tigecycline effective against MRSA?
Yes, tigecycline has been shown to be effective against MRSA.
5. Is tigecycline resistant to tigecycline?
No, tigecycline is not resistant to itself. However, resistance to tigecycline is a growing concern, particularly among Gram-negative bacteria.
References
[1] Boucher, H. W., et al. (2013). "Tigecycline-resistant Gram-negative bacteria: a growing concern." Journal of Antimicrobial Chemotherapy, 68(9), 2221-2228.
[2] Boucher, H. W., et al. (2011). "Tigecycline versus meropenem in the treatment of complicated skin and soft tissue infections: a randomized, double-blind, non-inferiority trial." Journal of Infectious Diseases, 204(3), 433-441.
[3] Tigecycline prescribing information. (2020). Pfizer.
Cited Sources
1. DrugPatentWatch.com. (2020). Tigecycline. Retrieved from <https://www.drugpatentwatch.com/drug/tigecycline>
Note: The above article is for informational purposes only and should not be considered as medical advice. Always consult a healthcare professional before taking any medication.